Fetal blood sampling and intrauterine transfusion

Karin A. Fox, George Saade

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fetal blood sampling via cordocentesis, alternatively called percutaneous umbilical blood sampling, has improved the accuracy of diagnosis of fetal disorders, including hydrops, neonatal alloimmune thrombocytopenia, and genetic diseases. The ability to access the fetal vasculature allows timely intrauterine treatment, most commonly red blood cell or platelet transfusions. Such interventions have led to improved survival of infants who would have otherwise died in utero, from prematurity, or from late complications of disease. Appropriate patient selection and identification, monitoring, timely intervention, and a team approach between the obstetrician, maternal-fetal medicine specialist, and neonatologist are key to optimizing outcomes.

Original languageEnglish (US)
JournalNeoReviews
Volume13
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Cordocentesis
Intrauterine Blood Transfusion
Fetal Blood
Blood Transfusion
Neonatal Alloimmune Thrombocytopenia
Erythrocyte Transfusion
Platelet Transfusion
Inborn Genetic Diseases
Patient Selection
Edema
Mothers
Medicine
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Fetal blood sampling and intrauterine transfusion. / Fox, Karin A.; Saade, George.

In: NeoReviews, Vol. 13, No. 11, 11.2012.

Research output: Contribution to journalArticle

@article{e65fa0787ba04e1fa227bdf109c82a2f,
title = "Fetal blood sampling and intrauterine transfusion",
abstract = "Fetal blood sampling via cordocentesis, alternatively called percutaneous umbilical blood sampling, has improved the accuracy of diagnosis of fetal disorders, including hydrops, neonatal alloimmune thrombocytopenia, and genetic diseases. The ability to access the fetal vasculature allows timely intrauterine treatment, most commonly red blood cell or platelet transfusions. Such interventions have led to improved survival of infants who would have otherwise died in utero, from prematurity, or from late complications of disease. Appropriate patient selection and identification, monitoring, timely intervention, and a team approach between the obstetrician, maternal-fetal medicine specialist, and neonatologist are key to optimizing outcomes.",
author = "Fox, {Karin A.} and George Saade",
year = "2012",
month = "11",
doi = "10.1542/neo.13-11-e661",
language = "English (US)",
volume = "13",
journal = "Pediatrics in Review",
issn = "0191-9601",
publisher = "American Academy of Pediatrics",
number = "11",

}

TY - JOUR

T1 - Fetal blood sampling and intrauterine transfusion

AU - Fox, Karin A.

AU - Saade, George

PY - 2012/11

Y1 - 2012/11

N2 - Fetal blood sampling via cordocentesis, alternatively called percutaneous umbilical blood sampling, has improved the accuracy of diagnosis of fetal disorders, including hydrops, neonatal alloimmune thrombocytopenia, and genetic diseases. The ability to access the fetal vasculature allows timely intrauterine treatment, most commonly red blood cell or platelet transfusions. Such interventions have led to improved survival of infants who would have otherwise died in utero, from prematurity, or from late complications of disease. Appropriate patient selection and identification, monitoring, timely intervention, and a team approach between the obstetrician, maternal-fetal medicine specialist, and neonatologist are key to optimizing outcomes.

AB - Fetal blood sampling via cordocentesis, alternatively called percutaneous umbilical blood sampling, has improved the accuracy of diagnosis of fetal disorders, including hydrops, neonatal alloimmune thrombocytopenia, and genetic diseases. The ability to access the fetal vasculature allows timely intrauterine treatment, most commonly red blood cell or platelet transfusions. Such interventions have led to improved survival of infants who would have otherwise died in utero, from prematurity, or from late complications of disease. Appropriate patient selection and identification, monitoring, timely intervention, and a team approach between the obstetrician, maternal-fetal medicine specialist, and neonatologist are key to optimizing outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84868542382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868542382&partnerID=8YFLogxK

U2 - 10.1542/neo.13-11-e661

DO - 10.1542/neo.13-11-e661

M3 - Article

AN - SCOPUS:84868542382

VL - 13

JO - Pediatrics in Review

JF - Pediatrics in Review

SN - 0191-9601

IS - 11

ER -